Fjarde Ap-fonden’s Bio-Rad Laboratories Class A BIO Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-3,680	Closed	-$896K	–	498
2025 Q1	$896K	Buy	3,680 +200	+6%	+$60.2K	0.01%	502
2024 Q4	$1.14M	Buy	3,480 +1,200	+53%	+$407K	0.01%	507
2024 Q3	$763K	Buy	+2,280	New	+$724K	0.01%	507
2024 Q1	$1.35M	Sell	3,900 -300	-7%	-$98.7K	0.01%	513
2023 Q4	$1.36M	Buy	4,200 +100	+2%	+$31.3K	0.02%	508
2023 Q3	$1.47M	Buy	4,100 +3,300	+413%	+$1.27M	0.02%	509
2023 Q2	$303K	Hold	800	–	–	﹤0.01%	527
2023 Q1	$383K	Buy	+800	New	+$374K	0.01%	523
2022 Q4	–	Sell	-3,147	Closed	-$1.56M	–	520
2022 Q3	$1.56M	Hold	3,147	–	–	0.02%	519
2022 Q2	$1.56M	Sell	3,147 -2,200	-41%	-$1.15M	0.02%	519
2022 Q1	$3.01M	Sell	5,347 -1,003	-16%	-$605K	0.03%	487
2021 Q4	$4.8M	Sell	6,350 -250	-4%	-$187K	0.04%	409
2021 Q3	$4.92M	Sell	6,600 -300	-4%	-$225K	0.05%	403
2021 Q2	$4.45M	Sell	6,900 -200	-3%	-$122K	0.04%	445
2021 Q1	$4.05M	Buy	7,100 +600	+9%	+$355K	0.04%	451
2020 Q4	$3.79M	Sell	6,500 -1,500	-19%	-$854K	0.04%	453
2020 Q3	$4.12M	Hold	8,000	–	–	0.04%	397
2020 Q2	$3.61M	Sell	8,000 -600	-7%	-$265K	0.05%	401
2020 Q1	$3.02M	Buy	8,600 +1,500	+21%	+$552K	0.05%	378
2019 Q4	$2.63M	Buy	+7,100	New	+$2.5M	0.03%	511